<DOC>
	<DOCNO>NCT00897078</DOCNO>
	<brief_summary>RATIONALE : Gathering information metabolic syndrome young patient survive acute lymphoblastic leukemia ( ALL ) may help doctor learn disease . PURPOSE : This phase I trial study metabolic syndrome young patient survive acute lymphoblastic leukemia healthy sibling volunteer .</brief_summary>
	<brief_title>Study Metabolic Syndrome Young Patients Who Are Acute Lymphoblastic Leukemia Survivors Their Healthy Siblings</brief_title>
	<detailed_description>OBJECTIVES : - Determine prevalence metabolic syndrome ( MS ) component trait ( i.e. , obesity , hypertension , dyslipidemia , insulin resistance ) survivor childhood acute lymphoblastic leukemia healthy sibling volunteer . - Identify host- treatment-related risk factor MS. OUTLINE : This multicenter study . Patients ' medical chart review patient undergo anthropometric measuring ( height weight BMI calculation waist hip circumference ) blood pressure test . Patients also complete questionnaire physical activity , diet , family history 30-45 minute . Blood collected measure cytokine ( e.g. , adiponectin , leptin , interleukin-6 , C-reactive protein ) , fast glucose , fast insulin . Healthy volunteer undergo anthropometric measure blood pressure test ( see clinic ) . They also complete baseline medical history questionnaire physical activity diet .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Meets one follow eligibility criterion : Childhood acute lymphoblastic leukemia survivor Less 22 year old diagnosis Treated 19902007 one follow location : Fred Hutchinson Cancer Research Center and/or Children 's Hospital Regional Medical Center Seattle , WA Vanderbilt Children 's Hospital Nashville , TN Meets 1 follow treatment criterion : Completed conventional therapy ≥ 11 month ago first complete remission Received allogeneic hematopoietic cell transplantation ≥ 11 month ago complete remission No evidence recurrent disease Healthy volunteer Full sibling enrol cancer survivor Age 821 ( 1 eligible sibling , sibling close age prefer ) No history cancer PATIENT CHARACTERISTICS : Able speak , read , write English PRIOR CONCURRENT THERAPY : See Disease Characteristics No active treatment graftvshost disease Lack ability speak , read , write English Active treatment graft versus host disease</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>cancer survivor</keyword>
	<keyword>healthy , evidence disease</keyword>
	<keyword>long-term effect secondary cancer therapy child</keyword>
	<keyword>childhood acute lymphoblastic leukemia remission</keyword>
</DOC>